Announcements

ReACH Assistant/ Associate/Professor Opening

Please visit our Job Opportunities page for more information about this exciting opportunity! 

ReACH /IIMS Population Health Pilot Grant Program Deadline Extended to December 18th!

Click here for more information about this funding opportunity!
 
 

ReACH Director, Dr. Barbara J. Turner featured on Texas Public Radio's Texas Standard

On Friday, March 31st, Dr. Barbara J. Turner, the Director of the Center for Research to Advance Community Health (ReACH) will be featured on the Texas Public Radio show Texas Standard to discuss a recently published study that looks at how much the Hispanic community knows about chronic pain.  Dr. Turner and her team conducted a population-based survey representing 8.8 million Hispanic residents of five Southwestern states who did not have chronic pain.  The data from this study reveal serious gaps in knowledge about chronic pain including misunderstanding about relying on narcotics to treat the disease. This is the first study to reveal poor knowledge about chronic pain in a large population of Americans and reinforces the urgency of launching a broad-based educational campaign about chronic pain and its care. 
 
 

Contact Us

7411 John Smith Road

Suite 1050

San Antonio, TX

78229

 

Tel: 210-562-5551

Fax: 210-562-5560

Kate Aultman, PhD

Kate Aultman, PhD
Contact: 

Kathryn Aultman, PhD
Director of Research
Dean of the School of Health Professions
UT Health San Antonio
 
UT Health San Antonio
7703 Floyd Curl Drive
MSC: 6243
San Antonio, TX 78229
Phone: (210) 567-4845
Fax: (210) 567- 4828
Email: aultmank@uthscsa.edu

Kate Aultman, PhD is the Director of Research at the School of Health Professions at UT Health San Antonio.  She received her PhD in biochemistry at Louisiana State University in Baton Rouge and her undergraduate degree at the University of New Orleans.  Her early research focused on metabolism, nutrition and heart disease but quickly transitioned to infectious disease.  A Science and Diplomacy Fellowship from AAAS provided the opportunity to work in the US Agency for International Development and the WHO Global Program on AIDS to develop programs to slow the spread of the HIV/AIDS pandemic and to work at the country level to develop AIDS Control Programs.  After that she transitioned to the National Institute of Allergy and Infectious Diseases, where she continued her focus on global infectious diseases and specialized on the vector borne diseases, including malaria, dengue, Chagas’ disease and sleeping sickness.  Important projects included sequencing of the genome of Anopheles gambiae, the most important mosquito vector of malaria in Africa and establishing an industry-academic-government partnership to develop novel products for vector control.  In 2005 she was recruited to the Bill and Melinda Gates Foundation to establish a vector control program there.  The focus of that program included expanded support for product development, including discovery of novel modes of action; practical efforts to interrupt pathogen transmission at the local or national level; and expansion and evolution of the international regulatory and policy framework for evaluating vector control products.  Throughout her time at the NIH and the Gates Foundation she worked to develop early stage investigators and their projects. In her position at UT Health she continues that work.